chr2-127069056-A-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_139343.3(BIN1):​c.412-25T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.324 in 1,608,512 control chromosomes in the GnomAD database, including 86,748 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). There are indicators that this mutation may affect the branch point..

Frequency

Genomes: 𝑓 0.33 ( 8602 hom., cov: 33)
Exomes 𝑓: 0.32 ( 78146 hom. )

Consequence

BIN1
NM_139343.3 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.796

Publications

9 publications found
Variant links:
Genes affected
BIN1 (HGNC:1052): (bridging integrator 1) This gene encodes several isoforms of a nucleocytoplasmic adaptor protein, one of which was initially identified as a MYC-interacting protein with features of a tumor suppressor. Isoforms that are expressed in the central nervous system may be involved in synaptic vesicle endocytosis and may interact with dynamin, synaptojanin, endophilin, and clathrin. Isoforms that are expressed in muscle and ubiquitously expressed isoforms localize to the cytoplasm and nucleus and activate a caspase-independent apoptotic process. Studies in mouse suggest that this gene plays an important role in cardiac muscle development. Alternate splicing of the gene results in several transcript variants encoding different isoforms. Aberrant splice variants expressed in tumor cell lines have also been described. [provided by RefSeq, Mar 2016]
BIN1 Gene-Disease associations (from GenCC):
  • myopathy, centronuclear, 2
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • centronuclear myopathy
    Inheritance: SD Classification: DEFINITIVE Submitted by: ClinGen
  • autosomal dominant centronuclear myopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • autosomal recessive centronuclear myopathy
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
This position, referring to a specific DNA site, is a probable branch point but is likely benign (scored 2 / 10, using the threshold of <=3). The score ranges from 0 to 10, with values ≤3 considered benign and >5 classified as pathogenic. Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 2-127069056-A-G is Benign according to our data. Variant chr2-127069056-A-G is described in ClinVar as Benign. ClinVar VariationId is 678128.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.397 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
BIN1NM_139343.3 linkc.412-25T>C intron_variant Intron 5 of 18 ENST00000316724.10 NP_647593.1 O00499-1A0A024RAF1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
BIN1ENST00000316724.10 linkc.412-25T>C intron_variant Intron 5 of 18 1 NM_139343.3 ENSP00000316779.5 O00499-1

Frequencies

GnomAD3 genomes
AF:
0.330
AC:
50157
AN:
151948
Hom.:
8591
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.402
Gnomad AMI
AF:
0.351
Gnomad AMR
AF:
0.230
Gnomad ASJ
AF:
0.266
Gnomad EAS
AF:
0.0952
Gnomad SAS
AF:
0.397
Gnomad FIN
AF:
0.336
Gnomad MID
AF:
0.342
Gnomad NFE
AF:
0.325
Gnomad OTH
AF:
0.291
GnomAD2 exomes
AF:
0.300
AC:
74848
AN:
249172
AF XY:
0.309
show subpopulations
Gnomad AFR exome
AF:
0.394
Gnomad AMR exome
AF:
0.180
Gnomad ASJ exome
AF:
0.260
Gnomad EAS exome
AF:
0.101
Gnomad FIN exome
AF:
0.334
Gnomad NFE exome
AF:
0.324
Gnomad OTH exome
AF:
0.303
GnomAD4 exome
AF:
0.323
AC:
470415
AN:
1456446
Hom.:
78146
Cov.:
32
AF XY:
0.324
AC XY:
235113
AN XY:
724820
show subpopulations
African (AFR)
AF:
0.406
AC:
13540
AN:
33380
American (AMR)
AF:
0.182
AC:
8138
AN:
44658
Ashkenazi Jewish (ASJ)
AF:
0.259
AC:
6751
AN:
26080
East Asian (EAS)
AF:
0.0879
AC:
3485
AN:
39660
South Asian (SAS)
AF:
0.405
AC:
34916
AN:
86184
European-Finnish (FIN)
AF:
0.336
AC:
17645
AN:
52548
Middle Eastern (MID)
AF:
0.321
AC:
1847
AN:
5754
European-Non Finnish (NFE)
AF:
0.330
AC:
365233
AN:
1107968
Other (OTH)
AF:
0.313
AC:
18860
AN:
60214
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
17298
34597
51895
69194
86492
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
11804
23608
35412
47216
59020
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.330
AC:
50203
AN:
152066
Hom.:
8602
Cov.:
33
AF XY:
0.329
AC XY:
24453
AN XY:
74336
show subpopulations
African (AFR)
AF:
0.402
AC:
16685
AN:
41500
American (AMR)
AF:
0.230
AC:
3508
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
0.266
AC:
924
AN:
3468
East Asian (EAS)
AF:
0.0960
AC:
496
AN:
5168
South Asian (SAS)
AF:
0.396
AC:
1909
AN:
4822
European-Finnish (FIN)
AF:
0.336
AC:
3555
AN:
10582
Middle Eastern (MID)
AF:
0.344
AC:
101
AN:
294
European-Non Finnish (NFE)
AF:
0.325
AC:
22083
AN:
67934
Other (OTH)
AF:
0.295
AC:
623
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1735
3470
5204
6939
8674
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
502
1004
1506
2008
2510
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.320
Hom.:
3163
Bravo
AF:
0.317
Asia WGS
AF:
0.258
AC:
900
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jun 14, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Myopathy, centronuclear, 2 Benign:1
Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
12
DANN
Benign
0.54
PhyloP100
0.80
BranchPoint Hunter
2.0
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs67327804; hg19: chr2-127826632; COSMIC: COSV52117788; COSMIC: COSV52117788; API